NCT05551624View on ClinicalTrials.gov

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 4, 2018

Primary Completion Date

December 11, 2019

Study Completion Date

January 23, 2020

Conditions
Primary Immune Thrombocytopenia
Interventions
DRUG

Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet

Oral tablets administered daily, atorvastatin once a day and N-acetylcysteine every 8 hours

Trial Locations (1)

44280

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

All Listed Sponsors
lead

Hospital Civil de Guadalajara

OTHER

NCT05551624 - Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine | Biotech Hunter | Biotech Hunter